PROJECT FREDER1K STUDY IN SAXONY
Screening test for the risk of diabetes in newborns
The number of children developing type 1 diabetes is rising. In the information below, we would like to inform you about the Freder1k study on the ‘Early detection of the risk of developing type 1 diabetes’.
By testing a few drops of blood shortly after a baby is born, we can determine whether the infant is at increased risk for type 1 diabetes. If this is the case, additional tests at six months, two years and four years of age can determine whether the child is developing type 1 diabetes. If so, the disease can be treated in the best possible way, right from the start.
Participation in the study is voluntary and free of charge. The written consent of the child’s parents is required.
The Freder1k study is part of the GPPAD initiative and is run by Technische Universität Dresden, Leipzig University and Helmholtz Zentrum München in collaboration with maternity and paediatric hospitals in Saxony. The project began in the end of august 2016.
DFG – Center for Regenerative Therapies
Technische Universität Dresden
Prof. Dr. Ezio Bonifacio
Phone 0800 – 724 5148 (available only in Germany)